[HTML][HTML] Sudden death of COVID-19 patients in Wuhan, China: A retrospective cohort study

N Yang, K Tian, M Jin, X Zhang, F Zhang… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan
city and rapidly spread throughout China. So far, it has caused~ 4000 deaths in this country …

Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm

A Rabiu Abubakar, R Ahmad, AB Rowaiye, S Rahman… - Life, 2022 - mdpi.com
COVID-19-infected patients require an intact immune system to suppress viral replication
and prevent complications. However, the complications of SARS-CoV-2 infection that led to …

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis

J Gorham, A Moreau, F Corazza, L Peluso… - PLoS …, 2020 - journals.plos.org
Introduction Coronavirus disease 2019 (COVID-19) appeared in China in December 2019
and has spread around the world. High Interleukin-6 (IL-6) levels in COVID-19 patients …

COVID-19 cytokine storm syndrome: a threshold concept

LYC Chen, TTT Quach - The Lancet Microbe, 2021 - thelancet.com
The COVID-19 pandemic has placed the practice of medicine at a threshold overlooking a
new and different era, 1 and has led to the evolving concept of COVID-19 cytokine storm …

Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens

A Tanveer, B Akhtar, A Sharif, U Saleem, A Rasul… - …, 2022 - Springer
The Covid-19, a threatening pandemic, was originated from China in December 2019 and
spread quickly to all over the world. The pathogenesis of coronavirus is linked with the …

Basic predictive risk factors for cytokine storms in COVID-19 patients

SG Shcherbak, AY Anisenkova, SV Mosenko… - Frontiers in …, 2021 - frontiersin.org
Objective A critical role in coronavirus disease 2019 (COVID-19) pathogenesis is played by
immune dysregulation that leads to a generalized uncontrolled multisystem inflammatory …

[PDF][PDF] Association of interleukin-6 levels with morbidity and mortality in patients with coronavirus disease 2019 (COVID-19)

J Zhou, W He, J Liang, L Wang, X Yu, M Bao, H Liu - Jpn J Infect Dis, 2021 - niid.go.jp
The prognostic value of interleukin-6 in COVID-19 needs to be clarified. In this retrospective
study, COVID-19 patients treated in Renmin Hospital of Wuhan University from Jan 7 to Feb …

Risk factors for mortality of COVID-19 patient based on clinical course: a single center retrospective case-control study

J Zhang, Z Wang, X Wang, Z Hu, C Yang… - Frontiers in …, 2021 - frontiersin.org
Background: Epidemiological factors, clinical characteristics, and risk factors for the mortality
of COVID-19 patients have been studied, but the role of complementary systems, possible …

The cytokine storm in COVID-19: the strongest link to morbidity and mortality in the current epidemic

M Basheer, E Saad, N Assy - COVID, 2022 - mdpi.com
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. The clinical
presentations of the SARS-CoV-2 infection are widely variable and treatment strategies for …

Consecutive monitoring of interleukin-6 is needed for COVID-19 patients

X Chen, J Zhou, C Chen, B Hou, A Ali, F Li, Z Hua… - Virologica Sinica, 2021 - Springer
The world is facing an immense challenge in the fight against coronavirus disease 2019
(COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS …